The FDA's July 2026 review of seven peptides could have far-reaching implications beyond healthcare. As regulators evaluate potential changes to compounding eligibility, payment processors, banks, and merchants are watching closely. Learn how increased regulatory clarity may affect merchant account approvals, underwriting standards, banking relationships, and payment processing opportunities for businesses operating in the peptide industry.

What happens when you combine 2nd Amendment Processing, NMI, and Biller Genie? You get a fully integrated payment ecosystem that goes beyond processing transactions. Automate invoicing, streamline accounts receivable, improve cash flow, and give your customers a seamless payment experience—all backed by expert support and cutting-edge payment technology.